{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:36:00Z","timestamp":1790480160880,"version":"4.1.0"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00008\/1"],"award-info":[{"award-number":["MC_UU_00008\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2021,5,7]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with poor prognosis. Identifying patients early may allow intervention which could limit progression. The \u2018indeterminate for usual interstitial pneumonia\u2019 (iUIP) CT pattern, defined in the 2018 IPF guidelines, could be a precursor to IPF but there is limited data on how patients with iUIP progress over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the radiological progression of iUIP and explore factors linked to progression to IPF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of a lung fibrosis clinic cohort (n=230) seen between 2013 and 2017. Cases with iUIP were identified; first ever CTs for each patient found and categorised as 'non-progressor' or 'progressors' (the latter defined as increase in extent of disease or to 'definite' or 'probable' UIP CT pattern) during their follow-up. Lung function trends, haematological data and patient demographics were examined to explore disease evolution and potential contribution to progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>48 cases with iUIP CT pattern were identified. Of these, 32 had follow-up CT scans, of which 23 demonstrated progression. 17 patients in this cohort were diagnosed with IPF over a mean (SD) period of 3.9 (\u00b11.9) years. Monocyte (HR: 23, 95% CI: 1.6 to 340, p=0.03) and neutrophil levels (HR: 1.8, 95% CI: 1.3 to 2.3, p&lt;0.001), obtained around the time of initial CT, were associated with progression to IPF using Cox proportional hazard modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>53% of our evaluable patients with iUIP progressed to IPF over a mean of 4 years. Monocyte and neutrophil levels at initial CT were significantly associated with progression in disease. These data provide a single-centre analysis of the evolution of patients with iUIP CT pattern, and first signal for potential factors associated with progression to IPF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2021-000899","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T10:37:23Z","timestamp":1637318243000},"page":"e000899","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern"],"prefix":"10.1136","volume":"8","author":[{"given":"Andrew","family":"Achaiah","sequence":"first","affiliation":[{"name":"MRC Human Immunology Unit, University of Oxford, Headington, Oxford, UK"},{"name":"Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amila","family":"Rathnapala","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pereira","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Bothwell","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0915-7250","authenticated-orcid":false,"given":"Kritica","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Barker","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Benamore","sequence":"additional","affiliation":[{"name":"Thoracic Radiology Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K","family":"Hoyles","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Iotchkova","sequence":"additional","affiliation":[{"name":"Computational Biology and Statistics Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Headington, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Pei","family":"Ho","sequence":"additional","affiliation":[{"name":"MRC Human Immunology Unit, University of Oxford, Headington, Oxford, UK"},{"name":"Interstitial Lung Disease Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"2025083110423498000_8.1.e000899.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30866-8"},{"key":"2025083110423498000_8.1.e000899.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007285"},{"key":"2025083110423498000_8.1.e000899.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2025083110423498000_8.1.e000899.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2025083110423498000_8.1.e000899.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ro.2018.12.006"},{"key":"2025083110423498000_8.1.e000899.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01680-2015"},{"key":"2025083110423498000_8.1.e000899.7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70011-6"},{"key":"2025083110423498000_8.1.e000899.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212446"},{"key":"2025083110423498000_8.1.e000899.9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30433-2"},{"key":"2025083110423498000_8.1.e000899.10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30508-3"},{"key":"2025083110423498000_8.1.e000899.11","first-page":"72","article-title":"Idiopathic pulmonary fibrosis: significance of the usual interstitial pneumonia (UIP) CT-scan patterns defined in new international guidelines","volume":"77","author":"Diridollou","year":"2020","journal-title":"Respir Med Res"},{"key":"2025083110423498000_8.1.e000899.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0518"},{"key":"2025083110423498000_8.1.e000899.13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.623430"},{"key":"2025083110423498000_8.1.e000899.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201901-0180ED"},{"key":"2025083110423498000_8.1.e000899.15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30168-5"},{"key":"2025083110423498000_8.1.e000899.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146314"},{"key":"2025083110423498000_8.1.e000899.17","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-1296-3"},{"key":"2025083110423498000_8.1.e000899.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2111053"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2021-000899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:42:41Z","timestamp":1756662161000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2021-000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,11,19]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bmjresp-2021-000899"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2021-000899","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.20.21262390","asserted-by":"object"}]},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}